参考文献/References:
[1] 刘淼,王建华,王盛书,等. 中国高龄老年人血压水平和高血压患病及其控制情况[J]. 中华流行病学杂志,2019,40(3):290-295.
[2] 中国老年医学学会高血压分会. 高龄老年人血压管理中国专家共识[J]. 中国心血管杂志,2015,20(6):401-409..
[3] James PA,Oparil S,Carter BL,et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)[J]. JAMA,2014,311(5):507-520.
[4] Rosendorff C,Lackland DT,Allison M,et al. Treatment of hypertension in patients with coronary artery disease:a scientific statement from the American Heart Association,American College of Cardiology,and American Society of Hypertension[J]. Hypertension,2015,65(6):1372-1407.
[5] Qaseem A,Wilt TJ,Rich R,et al. Pharmacologic treatment of hypertension in adults aged 60 years or older to higher versus lower blood pressure targets:a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians[J]. Ann Intern Med,2017,166(6):430-437.
[6] Whelton PK,Carey RM,Aronow WS,et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection,evaluation,and management of high blood pressure in adults:executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines[J]. Hypertension,2018,1(6):1269-1324.
[7] Benetos A,Bulpitt CJ,Petrovic M,et al. An expert opinion from the European Society of Hypertension–European Union Geriatric Medicine Society working group on the management of hypertension in very old,frail subjects[J]. Hypertension,2016,67(5):820-825.
[8] Williams B,Mancia G,Spiering W,et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension:The Task Force for the management of arterial hypertension of the European Society of Cardiology(ESC) and the European Society of Hypertension(ESH)[J]. J Hypertens,2018,36(10):1953-2041.
[9] 中国高血压防治指南修订委员会. 中国高血压防治指南（2018年修订版）[J]．中国心血管杂志,2019,24(1):24-56．
[10]中国老年医学学会高血压分会. 中国老年高血压管理指南2019[J].中华老年多器官疾病杂志,2019,18(2):81-105.
[11]Unger T,Borghi C,Charchar F,et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines[J]. J Hypertens,2020,75(6):1334-1357.
[12]Williamson JD,Supiano MA,Applegate WB,et al. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged≥75 years:a randomized clinical trial[J]. JAMA,2016,315(24):2673-2682.
[13]Currie G,Delles C. Blood pressure targets in the elderly[J]. J Hypertens,2018,36(2):234-236.
[14]Nayor M,Duncan MS,Musani SK,et al. Incidence of cardiovascular disease in individuals affected by recent changes to US blood pressure treatment guidelines[J]. J Hypertens,2018,36(2):436-443.
[15]Lv YB,Gao X,Yin ZX,et al. Revisiting the association of blood pressure with mortality in oldest old people in China:community based,longitudinal prospective study[J]. BMJ,2018,361:k2158.
[16] Masoli JAH,Delgado J,Pilling L,et al. Blood pressure in frail older adults:associations with cardiovascular outcomes and all-cause mortality[J]. Age Ageing,2020,49(5):807-813.
[17] Pajewski NM,Berlowitz DR,Bress AP,et al. Intensive vs standard blood pressure control in adults 80 years or older:a secondary analysis of the systolic blood pressure intervention trial[J]. J Am Geriatr Soc,2020,68(3):496-504.
[18] Kjeldsen SE,Mancia G. The un-observed automated office blood pressure measurement technique used in the SPRINT study points to a standard target office systolic blood pressure<140 mmHg[J]. Curr Hypertens Rep ,2017,19(1):3.
[19] Rocco MV,Sink KM,Lovato LC,et al. Effects of intensive blood pressure treatment on acute kidney injury events in the systolic blood pressure intervention trial(SPRINT)[J]. Am J Kidney Dis,2018,71(3):352-361.
[20] Benetos A,Labat C,Rossignol P,et al. Treatment with multiple blood pressure medications,achieved blood pressure,and mortality in older nursing home residents:the partage study[J]. JAMA Intern Med,2015,175(6):989-995.
[21] Douros A,T?lle M,Ebert N,et al. Control of blood pressure and risk of mortality in a cohort of older adults:the Berlin Initiative Study[J]. Eur Heart J,2019,40(25):2021-2028.
[22] Stessman J,Bursztyn M,Gershinsky Y,et al. Hypertension and its treatment at age 90 years:is there an association with 5-year mortality?[J]. J Am Med Dir Assoc ,2017,18(3):277.e13-277.e19.
[23] Jonas M,Kazarski R,Chernin G. Ambulatory blood-pressure monitoring,antihypertensive therapy and the risk of fall injuries in elderly hypertensive patients[J]. J Geriatr Cardiol ,2018,15(4):284-289.
[24] Abell JG,Kivim?ki M,Dugravot A,et al. Association between systolic blood pressure and dementia in the Whitehall II cohort study:role of age,duration,and threshold used to define hypertension[J]. Eur Heart J,2018,39(33):3119-3125.
[25] Sabayan B,Oleksik AM,Maier AB,et al. High blood pressure and resilience to physical and cognitive decline in the oldest old:the Leiden 85-plus study[J]. J Am Geriatr Soc,2012,60(11):2014-2019.
[26] Ravindrarajah R,Hazra NC,Hamada S,et al. Systolic blood pressure trajectory,frailty and all-cause mortality over 80 years of age. Cohort study using electronic health records[J]. Circulation,2017,135(24):2357-2368.
[27]范利,李建华,胡亦新,等．合并不同并发症的老年高血压患者的衰弱检出率[J]. 中华高血压杂志,2015,23(12):1151-1155.
[28]Post Hospers G,Smulders YM,Maier AB,et al. Relation between blood pressure and mortality risk in an older population:role of chronological and biological age[J]．J Intern Med,2015,277(4):488-497.
[29]Vaes B,Depoortere D,van Pottelbergh G,et al. Association between traditional cardiovascular risk factors and mortality in the oldest old:untangling the role of frailty [J]. BMC Geriatr,2017,17(1):234.
[30]Chudiak A,Jankowska-Polańska B,Uchmanowicz I. Effect of frailty syndrome on treatment compliance in older hypertensive patients[J]. Clin Interv Aging,2017,12:805-814.
[31]Warwick J,Falaschetti E,Rockwood K,et al. No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people:an investigation of the impact of frailty upon treatment effect in the Hypertension in the Very Elderly Trial(HYVET) study,a double-blind,placebo controlled study of antihypertensives in people with hypertension aged 80 and over[J]. BMC Med,2015,13:78.
[32]Pajewski NM,Williamson JD,Applegate WB,et al. Characterizing frailty status in the Systolic Blood Pressure Intervention Trial [J]. J Gerontol A Biol Sci Med Sci,2016,71(5):649-655.
[33]Russo G,Liguori I,Aran L,et al. Impact of SPRINT results on hypertension guidelines:implications for “frail”elderly patients[J]. J Hum Hypertens,2018,32(8-9):633-638.
[34]Sink KM,Evans GW,Shorr RI,et al. Syncope,hypotension,and falls in the treatment of hypertension:results from the Randomized Clinical Systolic Blood Pressure Intervention Trial [J]. J Am Geriatr Soc,2018,6(4):679-686.
[35]Anker D,Santos-Eggimann B,Santschi V,et al. Screening and treatment of hypertension in older adults:less is more?[J] Public Health Rev,2018,39:26.
[36]Uchmanowicz I,Chudiak A, Jankowska-Polańska B, et al. Hypertension and frailty syndrome in old age:current perspectives[J]. Card Fail Rev,2017,3(2):102-107.
[37]Reeve E,Jordan V,Thompson W,et al. Withdrawal of antihypertensive drugs in older people[J]. Cochrane Database Syst Rev,2020,6(6):CD012572.
相似文献/References:
[1]徐娜,综述,袁晋青,等.高龄非血运重建急性冠状动脉综合征患者的抗血小板治疗进展[J].心血管病学进展,2016,(2):108.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.003]
XU Na,YUAN Jinqing.Progress of Antiplatelet Therapy in Senior Patients with Acute
Coronary Syndrome without Revascularization[J].Advances in Cardiovascular Diseases,2016,(3):108.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.003]
[2]孙刚,黄冠华,综述.高血压合并心力衰竭的治疗策略[J].心血管病学进展,2016,(2):201.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.027]
SUN Gang,HUANG Guanhua.Treatment Strategy of Hypertension with Heart Failure[J].Advances in Cardiovascular Diseases,2016,(3):201.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.027]
[3]范贵娟,综述,徐瑞,等.盐敏感性高血压的研究进展[J].心血管病学进展,2016,(4):364.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.010]
FAN Guijuan,XU Rui.Research Progress of Salt Sensitive Hypertension[J].Advances in Cardiovascular Diseases,2016,(3):364.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.010]
[4]陈源源.钙通道阻滞剂在降压治疗中的应用[J].心血管病学进展,2015,(6):662.[doi:10.3969/j.issn.1004-3934.2015.06.002]
CHEN Yuanyuan.Application of Calcium Channel Blockers in Hypertension Treatment[J].Advances in Cardiovascular Diseases,2015,(3):662.[doi:10.3969/j.issn.1004-3934.2015.06.002]
[5]张瑞 毛露 孙硕 Dirk Hermann 陈艾东.内皮素-1干预成为高血压治疗新靶点的展望[J].心血管病学进展,2019,(7):969.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.000]
ZHANG Rui MAO LuSUN ShuoDIRK Hermann CHEN Aidong.The Prospect of Endothelin-1 Intervention as A New Target for the Treatment of Hypertension[J].Advances in Cardiovascular Diseases,2019,(3):969.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.000]
[6]张毅,柳志红.动态血压监测在高血压中的应用现状与问题[J].心血管病学进展,2019,(6):848.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.003]
ZHANG Yi,LIU Zhihong.Current status and nsolved Pproblems of Ambulatory Blood Pressure Monitoring for the Management of Hypertension[J].Advances in Cardiovascular Diseases,2019,(3):848.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.003]
[7]黄秋瑾 胡蓉.高血压合并糖尿病患者血压控制率和控制目标的探讨[J].心血管病学进展,2019,(7):973.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.002]
HUANG QiujinHU Rong.Discussion on Blood Pressure Control Rate and Control Target in Patients with Hypertension Complicated with Diabetes[J].Advances in Cardiovascular Diseases,2019,(3):973.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.002]
[8]张旭明 王曦.高血压对认知功能的影响[J].心血管病学进展,2019,(7):977.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.003]
ZHANG Xuming,WANG Xi.The Relationship Between Hypertension and Cognitive Function[J].Advances in Cardiovascular Diseases,2019,(3):977.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.003]
[9]凌梦军 陈明凌梦军.阻塞性睡眠呼吸暂停低通气综合征与高血压关系的研究进展[J].心血管病学进展,2019,(5):722.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.015]
[10]李波 郭毅 田进文 邓珏琳.高血压合并2型糖尿病的治疗进展[J].心血管病学进展,2019,(9):1196.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.002]
LI Bo,GUO Yi,TIAN Jinwen,et al.Therapy in Hypertensive Patients with Type 2 Diabetes Mellitus[J].Advances in Cardiovascular Diseases,2019,(3):1196.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.002]